← Markets

Addus HomeCare Corporation

ADUS · NASDAQ

Market closed$114.52$0.700000 (+0.62%)After hours $112.80 · -1.50%

Key statistics

Previous close$113.82
Open$114.57
Day high$116.42
Day low$113.59
52-week high$124.44
52-week low$87.95
Market cap2.14B
Volume211.06K
Average volume259.19K
P/E ratio17.78
Forward P/E13.47
EPS6.44
Dividend yield0.00%

Market context

Why it moved

ADUS shares moved higher after the stock crossed above its 200-day moving average, buoyed by better-than-expected earnings results and a generally positive analyst consensus with a "Moderate Buy" rating and a price target well above current levels.

MarketbeatBusiness InsiderAialosangelesCostulessdirectWindowscentral

What is happening

Recent company-specific developments and publisher coverage.

July 16, 2026Addus HomeCare surged after closing up 3.31%, outperforming the broader healthcare sector (XLV), as positive sentiment from UnitedHealth Group's blockbuster Q2 earnings beat lifted managed care and home health names. The tailwind came despite earlier-session pressure on ADUS following news of its $350 million acquisition of Gentiva's personal care operations — funded partly by a 1.5 million share equity offering — which had initially weighed on the stock due to dilution concerns. Investors appeared to look past the near-term dilution, focusing instead on the deal's strategic expansion into Texas and the broader healthcare sector rally sparked by UNH's raised full-year guidance and improved medical cost ratios.

3.3131

July 15, 2026Addus HomeCare shares gained after Barclays raised its price target, highlighting the stock among small-cap names with high upside potential. The advance comes as the broader healthcare sector navigates mixed headwinds, including HCA Healthcare's profit forecast cut tied to rising uninsured patient volumes and a nursing shortage worsening from 28% to 39% — pressures less directly relevant to Addus's home-based care model. UBS upgraded its sector outlook, citing improving earnings revisions and a stabilizing regulatory environment, while the S&P 500 closed near 52-week highs buoyed by a softer-than-expected CPI report.

1.5392

July 14, 2026Addus HomeCare closed modestly lower as the broader healthcare sector faced headwinds, with the XLV sector ETF retreating amid HCA Healthcare's warning that ACA exchange disruptions would exceed $1B in 2026 impacts — a reminder of policy and reimbursement risks facing care facilities. While Addus is less directly exposed to hospital uninsured-volume pressures, the sector-wide caution weighed on home care names, with investors also monitoring upcoming major insurer earnings from UnitedHealth and Elevance that could shape sentiment around Medicaid and Medicare reimbursement trends relevant to Addus's core personal care business.

-0.3307

July 14, 2026Addus HomeCare edged higher after Barclays raised its price target on the stock to $96 from $92 while maintaining an Underweight rating, signaling modest but cautious analyst acknowledgment of the company's positioning. The move comes as the broader healthcare sector faces headwinds heading into Q2 earnings season, with the XLV healthcare ETF trading slightly lower in after-hours; home care peers are also navigating a competitive landscape marked by active M&A and fresh capital deployments across the sector.

0.6007

July 10, 2026Addus HomeCare closed modestly lower, underperforming the healthcare sector (XLV essentially flat in after-hours) as investors digest the company's recent removal from multiple Russell indices — including the Russell 2000, 2500, and 3000 — following the annual June reconstitution. This index exclusion raises concerns about reduced demand from passive funds and potential shareholder base turnover. Offsetting some pressure, Q1 2026 earnings showed continued profitability with net income of $25.07M and diluted EPS of $1.36, and analysts project a fair value near $132, implying meaningful upside from current levels.

-1.3762

July 10, 2026Addus HomeCare gained over 3%, outperforming the broader healthcare sector (XLV essentially flat in after-hours) as investors reassessed the stock's valuation following a wave of analyst price target cuts tied to a new Medicare home health and hospice moratorium and the company's removal from several Russell growth benchmarks. Despite the headwinds — which prompted analysts to trim their consensus fair value from ~$143 to ~$133 and Barclays to maintain an Underweight with a $96 target — the stock has been resilient, with the session's advance building on a ~5% rally since Q1 earnings, where revenues of $363.6M rose 7.7% year-over-year but missed estimates slightly.

3.1979

July 8, 2026Addus HomeCare closed modestly higher, outperforming a broadly risk-off market rattled by renewed U.S.-Iran military strikes that drove oil prices sharply higher and weighed on major indices. The home-based personal care provider is navigating a complex backdrop: analysts have cut their consensus price target from ~$143 to ~$133, citing a new Medicare home health and hospice moratorium that constrains acquisition-driven growth and a more conservative revenue growth assumption (reduced from ~8% to ~5%). Compounding the overhang, Addus was dropped from multiple Russell growth and small-cap benchmarks in a recent rebalancing, a move that can trigger passive fund selling, though the stock has still rallied ~15% over the past 30 days. Healthcare broadly has been the market's top-performing sector over recent weeks, with XLV gaining ~6.6% in June and continuing to act as a defensive rotation play amid geopolitical uncertainty.

0.3303

July 7, 2026Addus HomeCare closed little changed as investors weighed its recent 30-day rally of nearly 15% against valuation concerns following its removal from several Russell growth and small-cap benchmarks, an event that can trigger passive fund selling. Q1 revenues of $363.6 million grew 7.7% year-over-year but missed analyst estimates by 0.7%, while healthcare broadly has been the market's top-performing sector for two consecutive weeks, with XLV near its 52-week high — a tailwind for home care names amid an aging population thesis.

0.227

Simply Wall Street · July 10, 2026Addus HomeCare’s Broad Russell Index Removal Might Change The Case For Investing In ADUSSeeking Alpha · May 24, 2026Addus HomeCare: Strong Position Amid An Opportunistic Market (NASDAQ:ADUS)Simply Wall Street · May 20, 2026Addus HomeCare Pursues Personal Care M&A As Shares Trade Below TargetsMcKnight's Senior Living · May 6, 2026Addus HomeCare, Diversified Healthcare Trust, National Health Advisors report first-quarter earningsMcKnights Home Care · May 6, 2026Medicaid self-directed care has a fraud problem, Addus CEO saysHome Health Care News · May 5, 2026Addus Enters Indiana With HomeCourt Acquisition, Lines Up Second DealBusiness Wire · May 4, 2026Addus HomeCare Announces First Quarter 2026 Financial ResultsHospice News · February 24, 2026Addus Re-Ignites Hospice Acquisition Engine
Benzinga · July 9, 2026Barclays Maintains Underweight on Addus HomeCare, Raises Price Target to $96
Benzinga · May 18, 2026Citizens Reiterates Market Outperform on Addus HomeCare, Maintains $142 Price Target
Benzinga · May 15, 2026Barclays Maintains Underweight on Addus HomeCare, Lowers Price Target to $92
Benzinga · May 6, 2026Citizens Maintains Market Outperform on Addus HomeCare, Lowers Price Target to $142
Benzinga · May 5, 2026Addus HomeCare Q1 2026 Earnings Call: Complete Transcript
Mt Newswire · May 4, 2026Addus HomeCare Q1 Adjusted Earnings, Revenue Increase
Mt Newswire · May 4, 2026Earnings Flash (ADUS) Addus HomeCare Corporation Posts Q1 Adjusted EPS $1.62 per Share, vs. FactSet Est of $1.54
Mt Newswire · May 4, 2026Earnings Flash (ADUS) Addus HomeCare Corporation Reports Q1 Revenue $363.6M, vs. FactSet Est of $366.4M

Peers

S&P 500SPX · $7,457.69-1.01%Aveanna Healthcare Holdings Inc.AVAH · $9.69-2.12%Enhanced Group Inc. Class AENHA · $2.98+18.25%The Pennant Group, Inc.PNTG · $41.95+0.58%BrightSpring Health Services, Inc. Common StockBTSG · $70.69+3.71%Chemed CorporationCHE · $510.03+1.70%National HealthCare CorporationNHC · $228.16+1.57%Acadia Healthcare Company, Inc.ACHC · $34.50+2.65%Encompass Health CorporationEHC · $112.21-0.25%Premier Air Charter Holdings Inc.PREM · $0.055000+19.57%Privia Health Group, Inc.PRVA · $26.90-1.18%Astrana Health, Inc.ASTH · $44.94-0.35%